SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A slight decline in the revenue of Rs. 0.00 millions was seen for the September 2023 quarter as against Rs. 0.00 millions during year-ago period.The Net Loss for the quarter ended September 2023 is Rs. -1.46 millions as compared to Net Loss of Rs. -1.04 millions of corresponding quarter ended September 2022 Operating profit Margin for the quarter ended September 2023 further decreased to -0.86% as compared to -0.44% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.86 -0.44 95.45 -1.25 -0.76 64.47 -2.11 -1.78 18.54
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.86 -0.44 95.45 -1.25 -0.76 64.47 -2.11 -1.78 18.54
Depreciation 0.60 0.60 0.00 1.11 1.12 -0.89 2.26 2.26 0.00
PBT -1.46 -1.04 40.38 -2.36 -1.88 25.53 -4.37 -4.04 8.17
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -1.46 -1.04 40.38 -2.36 -1.88 25.53 -4.37 -4.04 8.17
Equity 264.19 264.19 0.00 264.19 264.19 0.00 264.19 264.19 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Citurgia Biochem Share Price

93.51 -1.88 (-1.97%)
07-May-2026 16:01 View Price Chart
Peers
Company Name CMP
BASF India 3869.00
Tata Chemicals 803.00
SRF 2771.90
Pidilite Inds. 1451.20
Deepak Nitrite 1850.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×